These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13160058)

  • 21. [Use of electrocardiography in experimental intoxication with Clostridium perfringens A toxin].
    ORESCANIN B; ANTIC R; ISVANESKI M
    Acta Med Iugosl; 1960; 14():433-45. PubMed ID: 13731136
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic-induced expression of a cryptic cpb2 gene in equine beta2-toxigenic Clostridium perfringens.
    Vilei EM; Schlatter Y; Perreten V; Straub R; Popoff MR; Gibert M; Gröne A; Frey J
    Mol Microbiol; 2005 Sep; 57(6):1570-81. PubMed ID: 16135225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection.
    Bos J; Smithee L; McClane B; Distefano RF; Uzal F; Songer JG; Mallonee S; Crutcher JM
    Clin Infect Dis; 2005 May; 40(10):e78-83. PubMed ID: 15844055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of the recombinant beta2 toxin (CPB2) from an enterotoxaemic bovine Clostridium perfringens strain and production of a specific immune serum.
    Lebrun M; Filée P; Galleni M; Mainil JG; Linden A; Taminiau B
    Protein Expr Purif; 2007 Sep; 55(1):119-31. PubMed ID: 17562369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium perfringens toxin types from freshwater fishes in one water reservoir of Shandong Province of China, determined by PCR.
    Cai Y; Gao J; Wang X; Chai T; Zhang X; Duan H; Jiang S; Zucker BA; Schlenker G
    Dtsch Tierarztl Wochenschr; 2008 Aug; 115(8):292-4, 296-7. PubMed ID: 18717056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotyping of Clostridium perfringens toxins using multiple oligonucleotide microarray hybridization.
    Al-Khaldi SF; Myers KM; Rasooly A; Chizhikov V
    Mol Cell Probes; 2004 Dec; 18(6):359-67. PubMed ID: 15488374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of xenon and nitrous oxide on in vitro guinea pig brain respiration and oxidative phosphorylation.
    LEVY L; FEATHERSTONE RM
    J Pharmacol Exp Ther; 1954 Feb; 110(2):221-5. PubMed ID: 13118496
    [No Abstract]   [Full Text] [Related]  

  • 30. [Animal experimental, histological and dosimetric studies on simple radiobiological models and their practical use. 3. Phosphorus-32 transport rate from the skin of guinea pigs].
    RAUSCH L
    Strahlentherapie; 1961 Aug; 115():593-8. PubMed ID: 14490591
    [No Abstract]   [Full Text] [Related]  

  • 31. [A method of indirect evaluation of the titer of absorption of phosphorus compounds at different levels of the digestive tract].
    FOURNIER P; DUPUIS Y
    J Physiol (Paris); 1953; 45(2):443-9. PubMed ID: 13131239
    [No Abstract]   [Full Text] [Related]  

  • 32. The enteric toxins of Clostridium perfringens.
    Smedley JG; Fisher DJ; Sayeed S; Chakrabarti G; McClane BA
    Rev Physiol Biochem Pharmacol; 2004; 152():183-204. PubMed ID: 15517462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of toxins of Bacillus perfringens on metabolism of phosphorus compounds in guinea pigs].
    BEREZOVSKAIA NN; IL'INA LI
    Biull Eksp Biol Med; 1954 Feb; 37(2):44-7. PubMed ID: 13160058
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dynamics of phosphorus compounds in the development of C1. perfringens].
    Maiorova IP; Blagoveshchenskii VA; Volkova ZM; Orlova NG
    Biokhimiia; 1965; 30(4):675-80. PubMed ID: 4286712
    [No Abstract]   [Full Text] [Related]  

  • 35. Uptake of P32 in resting cells of Clostridium perfringens.
    MALLIN ML; KAPLAN NO
    J Bacteriol; 1959 Feb; 77(2):125-30. PubMed ID: 13630859
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relation between central nervous system injury by Bacillus perfringens and Bacillus oedematiens toxins and the blood antitoxin titre].
    BULATOVA TI; MATVEEV KI
    Biull Eksp Biol Med; 1957 Mar; 43(3):71-5. PubMed ID: 13445983
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.